The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

It's not possible to take insulin ... Basaglar, Lantus, Toujeo, Semglee, Rezvoglar (insulin glargine) Your healthcare provider will tell you how much insulin you need to draw up from the vial for each ...

Insulin overdose symptoms can include confusion, fatigue, irritability, shaking, and other signs of low blood sugar (hypoglycemia). Insulin dosing is a multistep process that often requires careful ...

Samsung has since clarified that Bluetooth support for the S Pen is, in fact, gone. According to Samsung, the blog post was made in error, and the Galaxy S25 Ultra will not offer any Bluetooth ...

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest ...

(ABC 6 News) – On Monday, Attorney General Keith Ellison announced a settlement with Novo Nordisk that let’s Minnesotans buy its insulin products for $35 per month. For the next five years ...

ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...

The Minnesota Attorney General's Office announced a settlement has been reached with manufacturer Novo Nordisk over the high cost of insulin. The AG's office filed a lawsuit in 2018 against ...

While the Galaxy S25 phones are great to use as a daily driver, those who work with sketches or creative tasks might have a few questions related to the S Pen. The S Pen is hands-down an impressive ...

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...